CNK

Cinemark Holdings, Inc. NYSE

Communication Services ·Entertainment ·US · ir.cinemark.com

$27.00

Mkt Cap $3.2B

52w Low $21.60 43.5% of range 52w High $34.01

50d MA $28.21 200d MA $26.65

P/E (TTM) 23.4x

EV/EBITDA 11.3x

P/B 7.7x

Debt/Equity 9.3x

ROE 70.9%

P/FCF 15.2x

RSI (14) —

ATR (14) —

Beta 1.09

50d MA $28.21

200d MA $26.65

Avg Volume 2.3M

About

Cinemark Holdings, Inc., together with its subsidiaries, engages in the motion picture exhibition business. As of June 30, 2022, it operated 522 theatres with 5,868 screens in the United States, and South and Central America. The company was founded in 1984 and is headquartered in Plano, Texas.

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
May 1, 2026	BMO	-0.05	-0.06	-20.0%	29.52	-1.4%	-6.4%	-7.7%	—	—	—	—
Feb 18, 2026	BMO	0.24	0.16	-33.3%	25.36	-5.7%	+4.1%	+3.9%	+4.5%	+2.1%	+1.2%	—
Nov 5, 2025	BMO	0.44	0.40	-9.1%	26.75	+8.4%	+7.6%	+8.4%	+6.8%	+12.5%	+13.7%	—
Aug 1, 2025	BMO	0.78	0.63	-19.2%	26.87	+5.8%	-3.7%	-4.4%	-5.1%	-7.3%	-7.0%	—
May 2, 2025	BMO	-0.32	-0.32	+0.0%	29.89	-3.1%	+1.4%	-0.3%	+3.1%	+4.3%	+3.7%	—
Feb 19, 2025	BMO	0.39	0.33	-15.4%	33.06	-5.6%	-13.6%	-15.9%	-17.0%	-18.3%	-19.3%	—
Oct 31, 2024	BMO	0.56	1.19	+112.5%	30.48	-3.7%	-2.4%	-2.1%	-3.0%	-2.6%	+0.9%	—
Aug 2, 2024	BMO	0.10	0.32	+220.0%	23.09	+5.0%	+7.6%	+10.1%	+13.5%	+12.7%	+12.5%	—
May 2, 2024	BMO	-0.20	0.19	+195.0%	17.43	+5.0%	+0.9%	+1.7%	-2.4%	-0.3%	-0.3%	—
Feb 16, 2024	BMO	-0.16	-0.15	+6.2%	16.55	-0.6%	-0.1%	-0.7%	-1.5%	-2.8%	-1.6%	—
Nov 3, 2023	BMO	0.42	0.61	+45.2%	16.85	-0.4%	-2.4%	-9.5%	-8.5%	-11.4%	-12.1%	—
Aug 4, 2023	BMO	0.55	0.80	+45.5%	17.32	+3.9%	+1.2%	+4.3%	+6.0%	+1.2%	+2.9%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 30	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$29.01	$28.82	-0.7%	+1.8%	-4.8%	—	—	—
Apr 9	Wells Fargo	Maintains	Overweight → Overweight	—	$29.72	$29.62	-0.3%	+3.9%	+2.2%	+2.2%	+2.5%	+0.6%
Apr 8	JP Morgan	Maintains	Overweight → Overweight	—	$29.88	$30.79	+3.0%	-0.5%	+3.3%	+1.6%	+1.6%	+1.9%
Feb 19	Barrington Research	Maintains	Outperform → Outperform	—	$26.41	$26.94	+2.0%	-0.2%	+0.3%	-1.9%	-2.8%	-1.5%
Feb 18	Macquarie	Maintains	Outperform → Outperform	—	$25.36	$23.91	-5.7%	+4.1%	+3.9%	+4.5%	+2.1%	+1.2%
Jan 26	Barrington Research	Maintains	Outperform → Outperform	—	$24.01	$23.86	-0.6%	-1.5%	-3.7%	-2.0%	-3.2%	-1.4%
Jan 22	B. Riley Securities	Maintains	Neutral → Neutral	—	$24.18	$23.81	-1.5%	-0.2%	-0.7%	-2.2%	-4.4%	-2.7%
Jan 22	JP Morgan	Maintains	Overweight → Overweight	—	$24.18	$23.81	-1.5%	-0.2%	-0.7%	-2.2%	-4.4%	-2.7%
Jan 15	Macquarie	Maintains	Outperform → Outperform	—	$24.08	$24.01	-0.3%	+1.6%	-0.6%	+2.0%	+0.4%	+0.2%
Jan 14	Wells Fargo	Maintains	Overweight → Overweight	—	$23.09	$23.28	+0.8%	+4.3%	+5.9%	+3.6%	+6.3%	+4.7%
Dec 18	Morgan Stanley	Downgrade	Overweight → Equal Weight	—	$23.49	$23.02	-2.0%	-6.6%	-5.2%	-4.4%	-3.3%	-3.4%
Nov 6	JP Morgan	Maintains	Overweight → Overweight	—	$28.79	$28.79	+0.0%	+0.7%	-0.7%	+4.5%	+5.6%	+4.3%
Oct 21	Morgan Stanley	Maintains	Overweight → Overweight	—	$26.70	$26.62	-0.3%	+2.1%	-1.5%	-1.0%	-1.1%	+1.3%
Oct 9	JP Morgan	Maintains	Overweight → Overweight	—	$25.73	$25.90	+0.7%	+3.4%	+0.1%	-2.5%	+1.7%	+4.9%
Sep 23	Barrington Research	Maintains	Outperform → Outperform	—	$28.00	$28.01	+0.0%	+3.5%	+2.0%	+1.4%	+2.1%	-1.6%
Aug 4	Barrington Research	Maintains	Outperform → Outperform	—	$25.87	$25.87	+0.0%	-0.7%	-1.4%	-3.7%	-3.4%	-4.1%
Aug 4	Roth Capital	Maintains	Buy → Buy	—	$25.87	$25.87	+0.0%	-0.7%	-1.4%	-3.7%	-3.4%	-4.1%
Aug 4	Wells Fargo	Maintains	Overweight → Overweight	—	$25.87	$25.87	+0.0%	-0.7%	-1.4%	-3.7%	-3.4%	-4.1%
Jul 11	Wedbush	Upgrade	Neutral → Outperform	—	$29.85	$30.37	+1.7%	-0.2%	+0.0%	-0.4%	+0.5%	+0.5%
Jul 9	Roth Capital	Maintains	Buy → Buy	—	$30.64	$30.14	-1.6%	-6.0%	-2.6%	-2.7%	-2.6%	-3.0%
Jul 2	Benchmark	Maintains	Buy → Buy	—	$30.10	$30.18	+0.3%	+0.3%	+2.0%	-0.8%	+1.8%	-4.3%
May 5	JP Morgan	Maintains	Overweight → Overweight	—	$30.30	$29.31	-3.3%	-1.7%	+1.7%	+2.9%	+2.3%	+3.1%
May 5	Barrington Research	Maintains	Outperform → Outperform	—	$30.30	$29.31	-3.3%	-1.7%	+1.7%	+2.9%	+2.3%	+3.1%
Apr 28	Wedbush	Maintains	Neutral → Neutral	—	$29.54	$29.73	+0.6%	+1.6%	+0.8%	+1.3%	+1.2%	+2.6%
Apr 11	JP Morgan	Upgrade	Neutral → Overweight	—	$27.18	$27.60	+1.5%	+2.8%	+2.1%	+3.7%	+3.1%	+5.0%
Feb 20	Morgan Stanley	Maintains	Overweight → Overweight	—	$28.57	$28.29	-1.0%	-2.7%	-3.9%	-5.5%	-6.7%	-9.1%
Feb 20	Macquarie	Maintains	Outperform → Outperform	—	$28.57	$28.29	-1.0%	-2.7%	-3.9%	-5.5%	-6.7%	-9.1%
Feb 20	Barrington Research	Maintains	Outperform → Outperform	—	$28.57	$28.29	-1.0%	-2.7%	-3.9%	-5.5%	-6.7%	-9.1%
Feb 20	JP Morgan	Maintains	Neutral → Neutral	—	$28.57	$28.29	-1.0%	-2.7%	-3.9%	-5.5%	-6.7%	-9.1%
Feb 20	Benchmark	Maintains	Buy → Buy	—	$28.57	$28.29	-1.0%	-2.7%	-3.9%	-5.5%	-6.7%	-9.1%
Feb 19	Barrington Research	Maintains	Outperform → Outperform	—	$33.06	$31.20	-5.6%	-13.6%	-15.9%	-17.0%	-18.3%	-19.3%
Jan 30	JP Morgan	Maintains	Neutral → Neutral	—	$29.02	$29.47	+1.6%	-0.6%	-1.3%	+0.4%	+1.6%	+5.3%
Jan 29	Wells Fargo	Maintains	Overweight → Overweight	—	$28.83	$28.66	-0.6%	+0.7%	+0.1%	-0.7%	+1.1%	+2.2%
Jan 10	Benchmark	Maintains	Buy → Buy	—	$30.43	$29.82	-2.0%	-0.9%	-2.2%	-3.5%	-4.5%	-6.1%
Dec 18	Morgan Stanley	Maintains	Overweight → Overweight	—	$31.56	$31.84	+0.9%	-2.0%	-0.6%	-2.3%	-3.4%	-2.7%
Dec 3	Benchmark	Maintains	Buy → Buy	—	$36.02	$35.89	-0.4%	-1.4%	-1.9%	-1.6%	-2.3%	-7.5%
Nov 27	Wells Fargo	Maintains	Overweight → Overweight	—	$32.84	$33.75	+2.8%	+4.1%	+5.1%	+9.7%	+8.1%	+7.6%
Nov 4	Barrington Research	Maintains	Outperform → Outperform	—	$29.85	$29.88	+0.1%	-0.9%	-0.5%	+3.0%	+5.8%	+5.6%
Nov 1	Macquarie	Maintains	Outperform → Outperform	—	$29.75	$29.82	+0.2%	+0.3%	-0.6%	-0.2%	+3.4%	+6.1%
Nov 1	Wells Fargo	Maintains	Overweight → Overweight	—	$29.75	$29.82	+0.2%	+0.3%	-0.6%	-0.2%	+3.4%	+6.1%
Nov 1	Wedbush	Downgrade	Outperform → Neutral	—	$29.75	$29.82	+0.2%	+0.3%	-0.6%	-0.2%	+3.4%	+6.1%
Oct 31	Barrington Research	Upgrade	Market Perform → Outperform	—	$30.48	$29.36	-3.7%	-2.4%	-2.1%	-3.0%	-2.6%	+0.9%
Oct 29	Wedbush	Maintains	Outperform → Outperform	—	$29.37	$29.25	-0.4%	+1.0%	+3.8%	+1.3%	+1.6%	+0.7%
Oct 14	JP Morgan	Maintains	Neutral → Neutral	—	$29.68	$29.67	-0.0%	-2.0%	-3.3%	-3.4%	-2.5%	-3.1%
Oct 11	Morgan Stanley	Maintains	Overweight → Overweight	—	$28.63	$29.06	+1.5%	+3.7%	+1.6%	+0.3%	+0.1%	+1.0%
Oct 10	Roth MKM	Maintains	Buy → Buy	—	$27.35	$27.55	+0.7%	+4.7%	+8.5%	+6.4%	+5.0%	+4.8%
Oct 10	Wells Fargo	Maintains	Overweight → Overweight	—	$27.35	$27.55	+0.7%	+4.7%	+8.5%	+6.4%	+5.0%	+4.8%
Sep 19	Goldman Sachs	Maintains	Sell → Sell	—	$28.62	$28.84	+0.8%	-1.0%	-1.0%	-3.5%	-3.2%	-6.1%
Sep 3	Wedbush	Maintains	Outperform → Outperform	—	$27.38	$27.45	+0.3%	-0.5%	+1.3%	+4.4%	+2.6%	+4.5%
Aug 28	Barrington Research	Downgrade	Outperform → Market Perform	—	$28.18	$27.63	-2.0%	-1.7%	-1.6%	-2.8%	-3.3%	-1.6%

Recent Filings

8-K · 7.01 ! Medium

Cinemark Holdings, Inc. -- 8-K 7.01: Regulation FD Disclosure

Cinemark Holdings disclosed its Q4 2025 financial results on February 18, 2026, providing investors with updated earnings performance and operational metrics for the period ending December 31, 2025.

Feb 18

Data updated apr 25, 2026 2:12am · Source: massive.com